🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆ Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity ◆ Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing ◆ Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich ◆ Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery ◆ Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma ◆ Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide ◆ The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany ◆ Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact ◆
Clinical Trials in Poland / NCT06200285
Recruiting Observational

International Registry of Accidental Hypothermia

NCT06200285 · tracked via the Priya Life Science Poland tracker
Phase
Observational
Started
2008-10-01
Last updated
2024-01-11

Condition(s) studied

Accidental Hypothermia

Investigational drug(s) / intervention(s)

Registry of patients with accidental hypothermia

Study summary

Transient mild hypothermia (core body temperature 35-32°C) is common and usually without consequences for the brain or other organs. However, prolonged severe accidental hypothermia (core body temperature below 28°C) due to accidents is rare, and usually fatal in more than 50% of cases. Little is known on its physiopathology, on prognostic factors for rewarming decision or ideal rewarming techniques for better survival. Furthermore, complications after successful rewarming are extremely frequent and very often severe or fatal.

Accidental hypothermia is a frequent problem during the winter months and can be caused by snow sport accidents, near drowning and urban cold exposure. The International Hypothermia Registry's principle goal is to increase knowledge on accidental hypothermia by creating the largest database on accidental hypothermia which will comprise enough patient data to give a statistical power since the causes of accidental hypothermia and its treatment varies greatly.

The International Hypothermia Registry (IHR) will enable improvement of pre- and in-hospital treatment and rewarming methods, study survival predictors and prevention of post-rewarming complications. By this way, the IHR will permit the establishment of evidence-based diagnosis and treatment guidelines.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Accidental hypothermia with body core temperatures equal or less than 35°C/95°F; * Any cause leading to accidental hypothermia (e.g. mountain, water, urban); * Any age, gender, or comorbidities; * Any pre-hospital and hospital treatment and rewarming; * Any outcome. Exclusion Criteria: * Patient opposition to be part of a study; * Essential missing values, e.g. temperature.

Primary outcome measure(s)

Trial sites (16)

FacilityCityRegionStatus
Medical University Innsbruck Innsbruck Austria Recruiting
Krankenhaus Barmherzige Brüder Salzburg Austria Recruiting
Rigshospitalet Copenhagen Denmark Recruiting
Klinik Immenstadt Immenstadt im Allgäu Germany Active Not Recruiting
ASST Bergamo Est Bergamo Italy Recruiting
EURAC Research Bolzano Italy Recruiting
Ospedale Santa Chiara Trento Italy Active Not Recruiting
Hokkaido Ohno Memorial Hospital Hokkaido Japan Recruiting
Medical University of Silesia Katowice Poland Recruiting
Vall d'Hebron University Hospital Barcelona Spain Recruiting
Hospital de Cerdanya Girona Spain Recruiting
Kantonsspital Chür Chur Switzerland Recruiting
Division of Anaesthesiology Geneva Switzerland Recruiting
Osepedale Regionale di Lugano Lugano Switzerland Recruiting
University Hospital Zürich Zurich Switzerland Recruiting
University of Portsmouth Portsmouth United Kingdom Active Not Recruiting

More University Hospital, Geneva trials in Poland

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06200285 on ClinicalTrials.gov ↗ ← All trials in Poland